文献速递皮肤肿瘤

非慢雀斑型/非肢端雀斑样原位黑色素瘤的局部复发与生存

Local Recurrence and Survival in Patients With Melanoma In Situ.
PubMed 文献 · JAMA Dermatol · 2025-09-03

这项回顾性队列研究纳入1991至2023年希腊401例非LM/非ALM原位黑色素瘤患者,中位随访5.2年。仅1例切缘阳性且未行扩大切除者出现局部复发并进展为浸润性黑色素瘤,无转移或黑色素瘤特异性死亡。诊断性切除活检切缘阴性可能足以治疗此类原位黑色素瘤。

要点

  • 非LM/非ALM原位黑色素瘤局部复发率极低,本队列仅1例复发。
  • 切缘阴性且未行扩大切除的30例患者中位随访8.1年无复发。
  • 扩大切除切缘窄于标准0.5cm的23例患者中位随访4.3年无复发。

核心结论

  • 诊断性切除活检切缘阴性可能足以治疗非LM/非ALM原位黑色素瘤,但需更大规模研究验证。

研究设计与样本

  • 回顾性队列研究,纳入1991至2023年希腊Andreas Sygros大学医院皮肤癌与黑色素瘤单元收治的401例非LM/非ALM原位黑色素瘤患者(403处皮损),中位随访5.2年。

主要发现

  • 401例患者中位年龄52岁,女性214例(53.4%),皮损最常见于躯干(201处,49.9%)。
  • 仅1例切缘阳性且未行扩大切除的患者在14个月后出现局部复发并进展为浸润性黑色素瘤。
  • 30例切缘阴性未行扩大切除的患者中位随访8.1年无复发;23例扩大切除切缘窄于0.5cm(平均0.36cm)的患者中位随访4.3年无复发。
  • 随访中6例(1.5%)切除瘢痕附近可疑复发病灶,病理示痣或日光性黑子;无患者发生转移或黑色素瘤特异性死亡。

关键数值与推荐

  • 所有皮损初始均行切除活检,372处(92.3%)后续行扩大切除。
  • 30处切缘阴性未行扩大切除的皮损中位随访8.1年无复发。
  • 23处扩大切除切缘窄于标准0.5cm(平均0.36cm,SD 0.07cm)的皮损中位随访4.3年无复发。

临床怎么用

  • 对于非LM/非ALM原位黑色素瘤,若诊断性切除活检切缘阴性,可考虑密切随访而非常规扩大切除。
  • 切缘阳性者应行扩大切除或密切监测,因本队列中唯一复发病例为切缘阳性未扩大切除者。

局限性

  • 本研究为单中心回顾性队列研究,样本量有限,需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The overdiagnosis of melanoma in situ (MIS) is well documented. There is limited evidence on the rate of local recurrence of the non-lentigo maligna (non-LM)/non-acral lentiginous melanoma (non-ALM) subtypes. OBJECTIVE: To investigate local recurrence and prognosis in non-LM/non-ALM MIS, the histopathological clearance of the excisional biopsy margins, and the association with the size of wide excision margins. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients with non-LM/non-ALM MIS diagnosed from 1991 to 2023 who were followed up for at least 1 year at the Skin Cancer and Melanoma Unit of Andreas Sygros University Hospital in Athens, Greece. Patients with a history of invasive melanoma or a histopathological diagnosis of LM or ALM in situ were excluded. Median (IQR) follow-up was 5.2 (2.9-7.9) years. Deidentified data on patient demographics and clinical characteristics, including the histopathological clearance of margins of the initial excisional biopsy and the size of margins of the wide excision, were obtained from medical records. MAIN OUTCOMES AND MEASURES: The primary outcomes were local recurrence, metastasis, and melanoma-specific survival. RESULTS: A total of 401 patients (214 [53.4%] women) with 403 non-LM/non-ALM MIS and a median (IQR) age of 52 (40-62) years were included in the analysis. MIS was frequently located on the trunk (201 lesions [49.9%]), followed by the lower extremity (99 [24.6%]), the upper extremity (71 [17.6%]), and the head and neck (32 [7.9%]). All lesions were initially treated with excisional biopsy, followed by wide excision for 372 (92.3%). There was only 1 local recurrence in a patient with involved margins at the excisional biopsy who did not undergo wide excision and developed an invasive melanoma 14 months later. Thirty lesions in 30 patients had clear excisional biopsy margins with no wide excision and had no recurrence at a median (IQR) follow-up of 8.1 (4.1-12.9) years. In 23 patients with 23 lesions that had wide excision with narrower than the standard 0.5-cm margins (mean [SD] margin size, 0.36 [0.07] cm), no recurrences were found at a median (IQR) follow-up of 4.3 (2.7-6.2) years. During follow-up, 6 patients (1.5%) developed a lesion suspicious for recurrence near the excision scar, which was excised and showed nevus or solar lentigo on histopathology. No patients had metastasis or melanoma-specific death. CONCLUSIONS AND RELEVANCE: This cohort study found that diagnostic excisional biopsies with clear margins may be sufficient for treating MIS; however, larger studies are necessary.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Dessinioti C, Befon A, Plaka M, et al. Local Recurrence and Survival in Patients With Melanoma In Situ. JAMA Dermatol. 2025. PMID: 40900523. doi:10.1001/jamadermatol.2025.3078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。